These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

609 related articles for article (PubMed ID: 32389025)

  • 21. Chloroquine and its derivatives in the management of COVID-19: A scoping review.
    Pimentel J; Andersson N
    Biomedica; 2020 Oct; 40(Supl. 2):80-95. PubMed ID: 33152192
    [TBL] [Abstract][Full Text] [Related]  

  • 22. COVID-19 and Antimalarial Drugs: Harms Outweigh Benefits.
    Halm MA
    Am J Crit Care; 2020 Nov; 29(6):489-492. PubMed ID: 32839815
    [No Abstract]   [Full Text] [Related]  

  • 23. Use of Hydroxychloroquine and Chloroquine During the COVID-19 Pandemic: What Every Clinician Should Know.
    Yazdany J; Kim AHJ
    Ann Intern Med; 2020 Jun; 172(11):754-755. PubMed ID: 32232419
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improving the efficacy of Chloroquine and Hydroxychloroquine against SARS-CoV-2 may require Zinc additives - A better synergy for future COVID-19 clinical trials.
    Shittu MO; Afolami OI
    Infez Med; 2020 Ahead of print Jun 1; 28(2):192-197. PubMed ID: 32335560
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potential of chloroquine and hydroxychloroquine to treat COVID-19 causes fears of shortages among people with systemic lupus erythematosus.
    Jakhar D; Kaur I
    Nat Med; 2020 May; 26(5):632. PubMed ID: 32269358
    [No Abstract]   [Full Text] [Related]  

  • 26. Chloroquine and Hydroxychloroquine in COVID-19: Practice Implications for Healthcare Professionals.
    Mallhi TH; Ahmad A; Butt MH; Misbah S; Khan YH; Alotaibi NH
    J Coll Physicians Surg Pak; 2020 Oct; 30(10):124-128. PubMed ID: 33115586
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chloroquine and hydroxychloroquine for the prevention and therapy of coronavirus disease 2019: new hopes and old cardiovascular concerns.
    Jankowska EA; Sierpiński R; Tkaczyszyn M; Drozd M; Szachniewicz J; Duda-Sikuła M; Knysz B; Simon K; Szenborn L; Ponikowski P
    Kardiol Pol; 2020 Aug; 78(7-8):811-817. PubMed ID: 32687267
    [No Abstract]   [Full Text] [Related]  

  • 28. Psychiatric Aspects of Chloroquine and Hydroxychloroquine Treatment in the Wake of Coronavirus Disease-2019: Psychopharmacological Interactions and Neuropsychiatric Sequelae.
    Hamm BS; Rosenthal LJ
    Psychosomatics; 2020; 61(6):597-606. PubMed ID: 32800347
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel approach for low-dose pulmonary delivery of hydroxychloroquine in COVID-19.
    Fassihi SC; Nabar NR; Fassihi R
    Br J Pharmacol; 2020 Nov; 177(21):4997-4998. PubMed ID: 32562278
    [No Abstract]   [Full Text] [Related]  

  • 30. Hydroxychloroquine or Chloroquine for Treatment or Prophylaxis of COVID-19: A Living Systematic Review.
    Hernandez AV; Roman YM; Pasupuleti V; Barboza JJ; White CM
    Ann Intern Med; 2020 Aug; 173(4):287-296. PubMed ID: 32459529
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Why Your Patients' Believing Hydroxychloroquine and Chloroquine Are 90% Effective for COVID-19 Is 100% Dangerous.
    White CM; Hernandez AV
    J Clin Pharmacol; 2020 Aug; 60(8):949-953. PubMed ID: 32530493
    [No Abstract]   [Full Text] [Related]  

  • 32. Regulators split on antimalarials for COVID-19.
    Jaffe S
    Lancet; 2020 Apr; 395(10231):1179. PubMed ID: 32278373
    [No Abstract]   [Full Text] [Related]  

  • 33. Chloroquine or Hydroxychloroquine for Management of Coronavirus Disease 2019: Friend or Foe?
    Schluenz LA; Ramos-Otero GP; Nawarskas JJ
    Cardiol Rev; 2020; 28(5):266-271. PubMed ID: 32769401
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessing the risk of seizures with chloroquine or hydroxychloroquine therapy for COVID-19 in persons with epilepsy.
    Pati S; Houston T
    Epilepsy Res; 2020 Sep; 165():106399. PubMed ID: 32559589
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The possible mechanisms of action of 4-aminoquinolines (chloroquine/hydroxychloroquine) against Sars-Cov-2 infection (COVID-19): A role for iron homeostasis?
    Quiros Roldan E; Biasiotto G; Magro P; Zanella I
    Pharmacol Res; 2020 Aug; 158():104904. PubMed ID: 32430286
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hydroxychloroquine as prophylaxis or treatment for COVID-19: What does the evidence say?
    Nina PB; Dash AP
    Indian J Public Health; 2020 Jun; 64(Supplement):S125-S127. PubMed ID: 32496241
    [TBL] [Abstract][Full Text] [Related]  

  • 37. COVID-19: Therapeutics and Their Toxicities.
    Chary MA; Barbuto AF; Izadmehr S; Hayes BD; Burns MM
    J Med Toxicol; 2020 Jul; 16(3):284-294. PubMed ID: 32356252
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Update on use of chloroquine/hydroxychloroquine to treat coronavirus disease 2019 (COVID-19).
    Gao J; Hu S
    Biosci Trends; 2020 May; 14(2):156-158. PubMed ID: 32281583
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A systematic review of the prophylactic role of chloroquine and hydroxychloroquine in coronavirus disease-19 (COVID-19).
    Shah S; Das S; Jain A; Misra DP; Negi VS
    Int J Rheum Dis; 2020 May; 23(5):613-619. PubMed ID: 32281213
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hydroxychloroquine and chloroquine: a potential and controversial treatment for COVID-19.
    Zou L; Dai L; Zhang X; Zhang Z; Zhang Z
    Arch Pharm Res; 2020 Aug; 43(8):765-772. PubMed ID: 32740801
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.